Balance innovation and compliance across IT, OT, and Quality while meeting 21 CFR Part 11 requirements.
About the Event
In GxP regulated environments, compliance is more than a box to check—it’s a shared responsibility across IT, OT, and Quality. As manufacturers modernize operations and innovate, they must still meet the complexities of 21 CFR Part 11. It’s a paradox—and it’s solvable.
Join industry experts Ron Sherrod (Regeneron), Joseph Iuliucci (Interloopal), and John Harrington (HighByte) for an in-depth discussion on balancing innovation with compliance in pharmaceutical manufacturing. Learn practical approaches, collaboration patterns, and enabling technologies that make modernization auditable, governable, and scalable.
Register nowThis session is designed for professionals in life sciences manufacturing—or any regulated industry—who are looking for insights into modern compliance strategies, collaborative approaches, and the technologies enabling innovation on the plant floor.
Experts from Regeneron, Interloopal, and HighByte.
Chief Product Officer • HighByte
John Harrington is the Chief Product Officer of HighByte, focused on defining the company’s business and product strategy. His areas of responsibility include product management, customer success, partner success, and go-to-market strategy.
Full Bio »
Staff Automation Engineer • Regeneron
Ron Sherrod is well-versed in process automation, having more than a decade of experience specializing in integrating diverse vendor systems while ensuring secure, high-performance architectures.
Full Bio »
Principal • Interloopal
Joseph Iuliucci is an innovation engineer and technologist dedicated to helping organizations connect their operations with digital ecosystems to achieve creative and transformative outcomes.
Full Bio »
Virtual Conference with Regeneron & HighByte | Nov 5 • 10 AM ET